6.
Hoekstra M, van Veelen N, van Leeuwen J, Nijdam M, Vermetten E
. 3MDR treatment in an adolescent with PTSD: a case report. Eur J Psychotraumatol. 2023; 14(2):2272487.
PMC: 10763824.
DOI: 10.1080/20008066.2023.2272487.
View
7.
Schottenbauer M, Glass C, Arnkoff D, Tendick V, Gray S
. Nonresponse and dropout rates in outcome studies on PTSD: review and methodological considerations. Psychiatry. 2008; 71(2):134-68.
DOI: 10.1521/psyc.2008.71.2.134.
View
8.
Feder A, Parides M, Murrough J, Perez A, Morgan J, Saxena S
. Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2014; 71(6):681-8.
DOI: 10.1001/jamapsychiatry.2014.62.
View
9.
Rothbaum B, Rizzo A, Difede J
. Virtual reality exposure therapy for combat-related posttraumatic stress disorder. Ann N Y Acad Sci. 2010; 1208:126-32.
DOI: 10.1111/j.1749-6632.2010.05691.x.
View
10.
Yamada K, Mizuno M, Nabeshima T
. Role for brain-derived neurotrophic factor in learning and memory. Life Sci. 2002; 70(7):735-44.
DOI: 10.1016/s0024-3205(01)01461-8.
View
11.
van Gelderen M, Nijdam M, Vermetten E
. An Innovative Framework for Delivering Psychotherapy to Patients With Treatment-Resistant Posttraumatic Stress Disorder: Rationale for Interactive Motion-Assisted Therapy. Front Psychiatry. 2018; 9:176.
PMC: 5946512.
DOI: 10.3389/fpsyt.2018.00176.
View
12.
Hamani C, Davidson B, Levitt A, Meng Y, Corchs F, Abrahao A
. Patient With Posttraumatic Stress Disorder Successfully Treated With Deep Brain Stimulation of the Medial Prefrontal Cortex and Uncinate Fasciculus. Biol Psychiatry. 2020; 88(11):e57-e59.
DOI: 10.1016/j.biopsych.2020.05.018.
View
13.
Vermetten E, Zhohar J, Krugers H
. Pharmacotherapy in the aftermath of trauma; opportunities in the 'golden hours'. Curr Psychiatry Rep. 2014; 16(7):455.
DOI: 10.1007/s11920-014-0455-y.
View
14.
Otalora G M, Grigsby J, Poulter B, Van Derveer 3rd J, Giron S, Jerome L
. 3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial. J Psychopharmacol. 2018; 32(12):1295-1307.
PMC: 6247454.
DOI: 10.1177/0269881118806297.
View
15.
Litz B, Stein N, Delaney E, Lebowitz L, Nash W, Silva C
. Moral injury and moral repair in war veterans: a preliminary model and intervention strategy. Clin Psychol Rev. 2009; 29(8):695-706.
DOI: 10.1016/j.cpr.2009.07.003.
View
16.
Kothgassner O, Goreis A, Kafka J, van Eickels R, Plener P, Felnhofer A
. Virtual reality exposure therapy for posttraumatic stress disorder (PTSD): a meta-analysis. Eur J Psychotraumatol. 2019; 10(1):1654782.
PMC: 6713125.
DOI: 10.1080/20008198.2019.1654782.
View
17.
Dunsmoor J, Niv Y, Daw N, Phelps E
. Rethinking Extinction. Neuron. 2015; 88(1):47-63.
PMC: 4598943.
DOI: 10.1016/j.neuron.2015.09.028.
View
18.
Smith-MacDonald L, Jones C, Brown M, Dunleavy R, VanderLaan A, Kaneva Z
. Moving Forward from Moral Injury: A Mixed Methods Study Investigating the Use of 3MDR for Treatment-Resistant PTSD. Int J Environ Res Public Health. 2023; 20(7).
PMC: 10094650.
DOI: 10.3390/ijerph20075415.
View
19.
van Deursen R, Jones K, Kitchiner N, Hannigan B, Barawi K, Bisson J
. The psychophysiological response during post-traumatic stress disorder treatment with modular motion-assisted memory desensitisation and reconsolidation (3MDR). Eur J Psychotraumatol. 2021; 12(1):1929027.
PMC: 8231381.
DOI: 10.1080/20008198.2021.1929027.
View
20.
Bisson J, van Deursen R, Hannigan B, Kitchiner N, Barawi K, Jones K
. Randomized controlled trial of multi-modular motion-assisted memory desensitization and reconsolidation (3MDR) for male military veterans with treatment-resistant post-traumatic stress disorder. Acta Psychiatr Scand. 2020; 142(2):141-151.
DOI: 10.1111/acps.13200.
View